Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2025-06-12 00:00:00 ET · period of report 2025-06-10 · accession 0000905148-25-002140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-12 | 2025-06-10 | ATRA | Touchon Pascal | Dir | A - Grant | $0.00 | +7,828 | 78.0K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-10 | A | A | 7,828 | $0.00 | 77,955 | D | — | — | (F1) These restricted stock units shall vest on the earlier of June 10, 2026 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service. |